Piet Van Riel

6PUBLICATIONS
33CO-AUTHORS
HaematologyDisease surveillanceRegenerative medicine (incl. stem cells)Cardiology (incl. cardiovascular diseases)Arts therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 18, 2025
Methotrexate associates with ischemic cardiovascular risk reduction in males but not females: a transatlantic cardiovascular consortium for people with rheumatoid arthritis observational study.

George A Karpouzas, Sarah R Ormseth, Piet Van Riel

|Mar 10, 2021
Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization.

Wieland D Müskens, Sanne A A Rongen-van Dartel, Carine Vogel

|Nov 02, 2020
Does Etanercept Biosimilar Prescription in a Rheumatology Center Bend the Medication Cost Curve?

Wieland D Müskens, Sanne A A Rongen-van Dartel, Piet L C M van Riel

|Oct 02, 2020
One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology.

Wieland D Müskens, Sanne A A Rongen-van Dartel, Steven Teerenstra

|Feb 24, 2020
Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centers.

Julia M Weijers, Anne G Semb, Silvia Rollefstad

|Oct 13, 2018
Tailored, Therapist-Guided Internet-Based Cognitive Behavioral Therapy Compared to Care as Usual for Patients With Rheumatoid Arthritis: Economic Evaluation of a Randomized Controlled Trial.

Maaike Ferwerda, Sylvia van Beugen, Henriët van Middendorp

Pageof 1

Frequent Collaborators

3 joint publications

Wieland D Müskens

3 joint publications

Sanne A A Rongen-van Dartel

3 joint publications

Eddy M M Adang

2 joint publications

Anne Grete Semb